EPISODE · Mar 7, 2025 · 15 MIN
864 - The Measles Outbreak in Texas and Beyond
from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health
About this episode: A measles outbreak that started in west Texas has sickened more than 150 people and killed a child. In today's episode: the scope of the outbreak and how it's spreading, the challenges of trying to control it, and claims about treatments including vitamin A, steroids, and antibiotics. Guest: Dr. Bill Moss is the executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Measles Outbreak Updates—Texas Department of State Health Services Measles Outbreaks in the U.S. Highlight the Importance of Vaccination—Johns Hopkins Bloomberg School of Public Health As Measles Spreads, Kennedy Embraces Remedies Like Cod Liver Oil—The New York Times The Story of Dean Sommer and Vitamin A—Johns Hopkins Bloomberg School of Public Health Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
NOW PLAYING
864 - The Measles Outbreak in Texas and Beyond
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m